0001062993-24-006109.txt : 20240311 0001062993-24-006109.hdr.sgml : 20240311 20240311160429 ACCESSION NUMBER: 0001062993-24-006109 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240307 FILED AS OF DATE: 20240311 DATE AS OF CHANGE: 20240311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nusse Roeland CENTRAL INDEX KEY: 0001492695 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 24737945 MAIL ADDRESS: STREET 1: 473 TENNESSEE CITY: PALO ALTO STATE: CA ZIP: 94306 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2024-03-07 0000842023 BIO-TECHNE Corp TECH 0001492695 Nusse Roeland 614 MCKINLEY PL NE MINNEAPOLIS MN 55413 1 0 0 0 0 Common Stock 2024-03-07 4 S 0 10400 76.9834 D 43097 D Stock Options (Right to Buy) 21.84 2016-10-29 2025-10-28 Common Stock 17040 17040 D Stock Options (Right to Buy) 25.30 2017-10-26 2026-10-27 Common Stock 15940 15940 D Stock Options (Right to Buy) 31.26 2018-10-25 2027-10-26 Common Stock 12500 12500 D Stock Options (Right to Buy) 44.96 2019-10-24 2028-10-25 Common Stock 7592 7592 D Stock Options (Right to Buy) 50.41 2020-10-24 2029-10-24 Common Stock 8044 8044 D Stock Options (Right to Buy) 63.92 2021-10-28 2030-10-29 Common Stock 6028 6028 D Stock Options (Right to Buy) 128.81 2022-10-27 2031-10-28 Common Stock 2532 2532 D Stock Options (Right to Buy) 73.94 2023-10-26 2032-10-27 Common Stock 3460 3460 D Stock Options (Right to Buy) 61.51 2033-10-26 Common Stock 3937 3937 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.955 to $77.11, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option vests on the earlier of the one year anniversary of the grant date (10/26/2023) or the date of Bio-Techne's 2024 annual meeting of shareholders. Andrew Nick as Attorney-in-Fact for Roeland Nusse pursuant to Power of Attorney previously filed 2024-03-11